Abstract Background: Tumor budding (TB) is showing increasing promise as a colorectal cancer (CRC) prognosticator that is independent of TNM staging. b-Catenin is a component of the Wingless/Wnt signaling pathway that is bound to membrane-associated E-cadherin and is essential for its correct position and function. Methods: This study was designed to detect TB in 44 resected primary CRC cases and also to compare b-catenin expression in the tumor budding sites (TBS) and in the tumor center. Tumor budding was assessed in both H&E and pankeratin immunostained sections. Agreement between TB scoring using pancytokeratin and H&E was tested. Also, typing of the tumor margin and determination of degree of cytoplasmic pseudo-fragmentation was done. Tumor budding, cytoplasmic pseudofragments and b-catenin expression were related to known CRC prognosticators. Results: Ten tumors (22.7%) showed low grade (LG) budding and 34 tumors (77.3%) showed high grade (HG) budding. The 34 HG budding tumors were further subdivided into moderate and severe (n = 13, n = 21, respectively) budding cancers. Twenty nine tumors (65.9%) showed LG cytoplasmic pseudofragments and 15 tumors (34.1%) showed HG pseudofragments. Scoring of TB on H&E and pankeratin stained sections revealed moderate agreement (Kappa = .558; p = <.000). A significant relation between TB and cytoplasmic pseudofragments was observed (p = .009). Both TB and cytoplasmic pseudofragments did not significantly associate with clinicopathologic parameters. Immunoreactivity of nuclear and cytoplasmic b-catenin was significantly higher at Journal of the Egyptian National Cancer Institute www.nci.cu.adu.eg www.sciencedirect.com TBS compared to tumor center (p = .005, p = .000, respectively). In opposition, membranous bcatenin expression was significantly higher in the tumor center than in TBS (p = .001). Although, nuclear b-catenin accumulation at TBS was noted, yet, it did not relate significantly with both TB and cytoplasmic pseudofragments around TBS (p = .649; p = .675, respectively). Also, nuclear b-catenin immunoreactivity did not relate significantly with the various clinicopathological variables. Conclusion: Pankeratin immunostaining facilitates typing of CRC invasive margin, and determination of the degree of TB and cytoplasmic pseudo-fragmentation. b-Catenin expression differs significantly between tumor center and TBS in CRC. Cut-offs for TB assessment should be unified and further studies are recommended to allow a better understanding of this process before establishing TB as a prognostic factor beyond the TNM staging in CRC.
Introduction
In most countries the decision whether or not to use adjuvant treatment for colorectal carcinoma (CRC) depends mainly on the clinicopathological staging that is carried out according to the tumor node metastasis (TNM) staging system. There is consensus that CRC patients with involved nodes will benefit from chemotherapy [1, 2] ; and rectal carcinomas infiltrating beyond the bowel wall are eligible for chemoradiation to reduce the risk of local failure, regardless of nodal status [3] . However, this stratification excludes the small but significant proportion of patients (10-15% of the total) who, despite being staged as low risk, follow an adverse clinical course with metachronous metastatic disease. Therefore, prognostic factors in addition to TNM are important issues for both clinical oncologists [1] and surgical pathologists [4, 5] .
Tumor-host interaction at the invasive front of colorectal cancer represents a critical interface where tumor progression and tumor cell dissemination ensue [6, 7] , with loss of cytological features of differentiation (de-differentiation of colorectal carcinoma cells); this corresponds to tumor budding [8] . TB is a peculiar pathologic feature of adenocarcinomas, especially colorectal and pancreaticobiliary carcinomas [1] . Tumor budding denotes the presence at the invasive front of a subset of colorectal adenocarcinomas of tiny cords and small aggregates of neoplastic epithelium that extend from neoplastic glands for a short distance into a desmoplastic stroma [9] . A detailed morphological study of TB has been published by Gabbert et al. [10] .
The role of tumor budding in the surgical pathology of colorectal carcinoma and its important link to tumor biology has largely escaped the attention of histopathologists [9] . Disintegration of cell adhesion molecules with modulation of E-cadherin-mediated adhesion is closely related to and is involved in tumor budding [8] .
b-Catenin is a component of the Wingless/Wnt signaling pathway that is bound to membrane-associated E-cadherin and is essential for its correct position and function [11] . Inactivation of the adenomatous polyposis coli (APC) gene that is the earliest frequent event in CRC leads to a cytoplasmic and subsequent nuclear accumulation of b-catenin [12] . Nuclear b-catenin acts as a transcriptional activator that activates genes necessary for cell proliferation, differentiation and invasive growth [8] . Thus, the intracellular distribution of bcatenin has a strong impact on the phenotype (tumor morphology) and behavior (i.e. aggressiveness) of tumor cells [8, 13] .
This study was designed to detect TB in resected primary colorectal carcinoma cases without pre-operative neoadjuvant treatment and to compare the expression of b-catenin between tumor budding sites and the tumor center. The histomorphologic features of tumor budding were assessed in H&E stained sections. Semiquantitative assessment of tumor budding at the tumor invasive front was achieved in both H&E and pancytokeratin immunostained tissue sections. Typing of the tumor margin, determination of the degree of TB and the degree of cytoplasmic pseudo-fragmentation were performed more accurately on the pancytokeratin immunostained slides. Tumor budding, cytoplasmic pseudofragments and nuclear b-catenin expression were related to known colorectal carcinoma prognosticators including venous angioinvasion, lymphatic permeation, serosal involvement, type of the margin, as well as the number of regional lymph nodes involved by metastatic deposits.
Material and methods

Patients
The present study included 44 consecutive surgically excised CRC specimens received at the Pathology Department, Faculty of Medicine, University of Alexandria, from January 2007 to March 2009. We excluded patients who underwent preoperative chemotherapy and emergency surgery. Patients' ages ranged from 26 to 80 years. The study was approved by Alexandria University, Faculty of Medicine Research Ethics Committee.
The formalin fixed paraffin-embedded (FFPE) tissue blocks were retrieved from the computer files and archives of the Pathology Department, Faculty of Medicine, Alexandria University. The original hematoxylin and eosin (H&E) stained sections of primary tumors were reviewed, and one paraffin block showing the tumor invasive front was chosen from each case for immunohistochemical studies.
Histological analysis of primary CRC features was done and included: determination of tumor histological type, grade, tumor growth pattern, lymphocytic infiltration at the advancing tumor margin, in addition to identifying tumor budding foci by conventional H&E staining. Also assessment of the regional lymph node status was done.
Staging was performed according to the tumor node metastasis (TNM) staging system [14] . Tumor type was determined by the criteria of the World Health Organization [15] . Growth pattern and lymphocytic infiltration at the advancing tumor margin were evaluated according to the criteria of Jass et al. [16] . Clinical and pathological data including patient age, sex, tumor site, size, and stage were obtained from the pathological and clinical records.
Immunohistochemistry
Five micron-thick sections, of FFPE tissue blocks were cut and mounted on coated slides. The sections were deparaffinized in xylene and rehydrated in descending ethanol grades. Sections were incubated for 10 min in 3% hydrogen peroxide to block endogenous tissue peroxidase. For pankeratin immunostaining, enzymatic antigen retrieval was done using trypsin (pre-heated to 37°C) by directly pipetting the solution onto the tissue on the slide and incubating it for 15 min in a 37°C incubator, whereas, for b-catenin heat retrieval was done in microwave oven using EDTA 1 mM (pH 8.0) for 45 min. Tissue sections were immunostained for pancytokeratin using a ready to use monoclonal antibody clone [AE1/AE3] (ab961), (Abcam, USA). Tissue sections were also stained for b-catenin using a mouse monoclonal antibody clone 14/b-catenin (Biocare Medical, LCC, USA) at a dilution of 1:100. The antigen-antibody reaction was visualized by Thermo Scientific UltraVision LP Detection System. Immunohistochemical reactions were developed with diaminobenzidine and sections counterstained with Harrris hematoxylin. All immunostains were manually processed. Appropriate positive and negative controls were included for each batch of slides.
Quantification of tumor budding
Tumor budding was assessed semiquantitatively in both H&E and pankeratin immunostained sections according to the method proposed by Ueno et al. [17] . The tumor border was scanned at 10· power in all cases and the area of most dense budding was identified. In the center of this area, tumor buds (single cells or clusters of up to 5 cells) were counted at 20· magnification.
Cases were then divided into two groups according to the number of tumor budding foci in the most dense field using an 20· objective lens. Counts of 0-9 were classified as low-grade, while counts of 10+ were classified as high-grade budding. High-grade budding was further divided into counts of 10-19 (moderate) and 20+ (severe) [18] . Agreement between TB scoring on H&E and pankeratin stained sections was tested.
Assessment of cytoplasmic fragments
Using pancytokeratin-immunostained sections, small nonnucleated cytoplasmic fragments were detected around tumor budding foci at the invasive tumor margin. Following the criteria published by Shinto et al. [18] cytoplasmic fragments to be counted had to be: at least 2 lm in diameter, non-nucleated, lacking evidence of nuclear fragmentation, uniformly positive for cytokeratin, smoothly contoured and free of surrounding inflammatory cells. Scores for each case were the highest number of fragments in a 20· objective lens field, and accordingly the 44 CRC cases were divided into low (0-9 fragments) and high grade (10+ fragments) for cytoplasmic pseudofragmentation [18] .
Evaluation of b-catenin immunostaining
Immunoreactivity of b-catenin was separately analyzed for the tumor center and the tumor budding sites. Staining intensity of membranous, cytoplasmic and nuclear b-catenin was graded as absent (0), mild (1), moderate (2), or severe (3) [8] . Overexpression of nuclear b-catenin was defined as a reactivity of >50% of the tumor cell nuclei [19] .
Statistics
Data were fed to the computer using the Predictive Analytics Software (PASW Statistics 18). Qualitative data were described using number and percent. Association between categorical variables was tested using the Chi-square test. When more than 20% of the cells have expected count less than 5, correction for Chi-square was conducted using the Fisher's Exact test (FET) or Yates' Chi-square test. The distributions of quantitative variables were tested for normality using the Kolmogorov-Smirnov test which revealed that data was not normally distributed. Thus, non-parametric statistics were applied. Quantitative data were described using median, minimum and maximum. Differences between two related quantitative variables were assessed using the Wilcoxon Signed Ranks (z) Test. An inter-rater reliability analysis using the Kappa statistic was performed to determine consistency between different diagnostic tools. Significance test results are quoted as two-tailed probabilities. Significance of the obtained results was judged at the 5% level.
Results
Clinicopathologic data
The studied cases included 12 male and 32 female with M:F 3:8. The age of patients ranged between 26 and 80 years (mean = 53.2 ± 13.6 years, median = 55.0 years). Eleven tumors (25%) were located in the right colon, 26 (59.1%) in the left colon, and 7 (15.9%) were in the rectum.
Immunohistochemistry
Using pancytokeratin immunostaining, the counting of tumor budding (TB) and cytoplasmic pseudofragments using 20· objective lens was done. Low grade budding (0-9 budding foci) was detected in 10 tumors (22.7%) (Fig. 1 ) whereas high grade budding (10+ budding foci) was detected in 34 tumors (77.3%) (Fig. 2) . The 34 high grade budding tumors were further stratified based on the number of tumor budding sites (TBS) into moderate (10-19 budding foci) and severe (20+ budding foci) (n = 13; 38.2%, n = 21; 61.8%, respectively) budding cancers. Twenty nine tumors (65.9%) showed low grade cytoplasmic pseudofragments (0-9 fragments) and 15 tumors (34.1%) showed high grade pseudofragments (10+ fragments) (Fig. 3) .
There was a strong significant relationship between tumor budding and cytoplasmic pseudofragments (FET; p = .009). All 10 low-grade tumor budding cancers (0-9 budding foci) (Tables 2  and 3) .
In this study, we compared b-catenin immunoreactivity at tumor center and tumor budding sites. A statistically significant difference was detected as regards b-catenin immunoreactivity between the tumor center and TBS. Immunoreactivity of both nuclear and cytoplasmic b-catenin was significantly higher at TBS than in the tumor center (z = 2.840; p = .005 and z= 5.406; p = .000, respectively), In opposition, membranous b-catenin expression was significantly higher in the tumor center than in tumor budding foci (z = 3.416; p = .001) (Figs. 4-6 ). An overexpression of nuclear b-catenin was defined as a reactivity of >50% of the nuclei. Accumulation of nuclear b-catenin at the invasive front (TB sites) was observed in 37 cases (84.1%) compared to only 2 cases (4.6%) that also showed nuclear b-catenin overexpression in tumor cells at the tumor center in addition to TBS (Figs. 7 and 8 ). When these staining results were related to the various clinical and pathological variables, no significant associations could be observed.
Nuclear b-catenin at the invasive front failed to relate significantly with both the degree of budding (FET; p = 0.675) and cytoplasmic pseudofragments (FET; p = 0.649) at the tumor invasive front (Tables 4 and 5 ).
The need for pancytokeratin immunostaining and tumor budding counting may be met by reservations on the part of histopathologists with a busy workload. With this practical aspect in mind, simple scoring of TB on H&E sections was done to test if it could work as a surrogate. Thus, all 44 studied cases were reviewed and classified as high or low in tumor budding by simple subjective scoring of H&E sections. Using this Figure 7 Microscopic appearance of the invasive front in colorectal carcinoma immunostained for b-catenin. Note that budding tumor cells express nuclear and cytoplasmic b-catenin (100·). approach, of 34 tumors classified as bud high on pancytokeratin immunostain, only 25 cases (73.5%) were classified as high in tumor budding on H&E sections. Conversely, all 10 cases rated bud low on pancytokeratin immunostain, were also classified as low in tumor budding on H&E sections. The agreement between the two methods (H&E and pankeratin immunostain) was moderate; Kappa = .558 (p < .000) (Figs. 9, 10 and Table 6 ).
Thus, there is a tendency to underestimate tumor budding on H&E sections and in a significant number of cases using pancytokeratin immunostains, surprisingly higher numbers of tumor buds will be seen lurking in a desmoplastic stroma closely intertwined with plump fibroblasts.
Discussion
Diagnosis and treatment of CRC have evolved considerably during recent years. Specifically, decisions for or against limited or full resections, and for or against adjuvant therapy are made largely on the basis of the histopathological findings [9] .
This study was undertaken to investigate the occurrence and histomorphologic features of TB in primary untreated CRC. TB and the related phenomenon of cytoplasmic pseudo-fragmentation were assessed semiquantitatively relating them to known CRC prognosticators. Also, expression of bcatenin between TBS and tumor center was compared to evaluate whether EMT occurs at TBS.
Although TB is showing increasing promise in clinicopathological studies as a prognostic factor in CRC independent of TNM staging [1, 9, [20] [21] [22] , still yet, it has not been implemented into daily diagnostic routine because of absence of standardized scoring systems and sufficient evidence of inter-observer reproducibility for selected evaluation methods [23] .
Prerequisites for any parameter to be valid as a prognostic marker include simplicity, reproducibility and objectivity. Tumor budding can be assessed objectively by counting on H&E stained sections representing tumor invasive front, however, cytokeratin immunostaining allows more accurate assessment. Previous studies revealed that the reproducibility among histopathologists of budding measured either by intraobserver semiquantitative agreement or by interobserver agreement with regard to the presence or absence was high [8, 20, 24] .
Two different types of scoring systems have been proposed: subjective and more quantitative/objective. In 1993, Hase et al. [25] presented a system based on using a 2-tier method (none or minimal versus moderate or severe). Nakamura et al. [22, 26] described TB along the entire invasive margin using a 4-tier method (none, mild <1/3, moderate 1/3-2/3 and severe >2/3). The group of Ueno et al. reported quantitative scoring by counting the number of buds within the field of most dense TB using a 20· objective lens with a cut-off of 10 buds with inter-observer agreement of Kappa = 0.84 [17, 20] . Wang et al. evaluated five randomly selected areas, each was given a score based on presence (at least one bud) or absence of TB in each field (area 0.949 mm 2 ) and they document an interobserver agreement of Kappa = 0.75 [27] . Prall et al. [1] scored pankeratin-stained tumor buds using an established statistical cutpoint determination method (receiver operating characteristic (ROC) curve analysis) classifying tumors of P25 buds/field in a 0.785 mm 2 field of vision (250·) as positive, with strong inter-observer agreement of Kappa = 0.874.
In the present study, semiquantitative assessment of TB was undertaken on pan-keratin stained sections. At low magnification, tumor buds were highlighted extremely well and the selection of a counting area as well as the counting itself was an easy and rapid procedure, an aspect which is important if an application in routine surgical pathology is envisioned. We also semiquantitatively assessed TB on H&E stained sections to assess the consistency between both methods (H&E versus pankeratin immunostain). Although the agreement between the two methods was moderate; Kappa = .558 (p < .000), however, a tendency to underestimate TB on H&E sections was observed as nine cases (26.5%) classified as bud low on H&E sections, using pancytokeratin immunostains, surprisingly showed higher numbers of tumor buds lurking in a desmoplastic stroma closely intertwined with plump fibroblasts. Thus, these nine cases were classified as bud high based on pankeratin immunostained sections.
The morphological link between TB and tumor cell migration at the invasive margin by pseudopod formation was recently proposed by Shinto et al. [18] who pointed out that, on high magnification in the immediate vicinity of tumor buds, pancytokeratin immunostain revealed non-nucleated cytoplasmic droplets to which the term 'cytoplasmic pseudo-fragments' was applied after demonstrating on step sections that these structures are continuous with the cytoplasm of budding tumor cells. These cytoplasmic pseudo-fragments were interpreted as podia-like cytoplasmic extensions which are thought to be a marker of an activated budding phenotype associated with cell motility and increased invasiveness during tumor cell migration.
Similarly, and to the best of our knowledge, we are the second study to document the presence of this new feature. Cytoplasmic pseudo-fragments were detected in the stroma surrounding budding foci and were found to strongly associate with TB (p = .009). Also, in accordance with Shinto et al. [18] our study revealed the absence of a significant relation between the extent of budding (within CRCs showing high-grade budding) and cytoplasmic pseudo-fragments (p = .217), thus, implying that the extent of budding and cytoplasmic pseudofragments are indicative of different mechanisms of tumor aggressiveness.
Epithelial mesenchymal transition (EMT) is proposed as a critical mechanism for the acquisition of malignant phenotypes by epithelial cells. In CRC, tumor cells having undergone EMT are histologically represented by the presence of tumor buds [23] . The suggested scenario is: adhesion junctions mediated by E-cadherin are broken up and tumor cell complexes dissociate, reorganization of the actin cytoskeleton allows budding tumor cells to extend podia into the migration direction. Tumor budding in this scenario is highly dynamic [9] .
This study, as putative direct evidence of Wnt dysregulation, revealed a striking pattern of b-catenin immunostaining in CRC. Cytoplasmic and nuclear b-catenin expression increased significantly in TBS compared to tumor center sites, whereas, membranous b-catenin decreased significantly in TBS compared with the tumor center. When all these staining results were related to the various clinical and pathological variables, no significant associations were observed. The finding that tumor buds shows a strong and uniform nuclear b-catenin staining with concomitant loss of membranous E-cadherin expression was reported by Zlobec and Lugli [23] and further augment previous findings of EMT studies [9, [28] [29] [30] [31] which reported that toward the center of a CRC the neoplastic glands show membranous b-catenin immunostaining, but in tumor buds this membranous immunostaining is lost, and instead, immunostaining of the tumor cell nuclei is very strong.
In our study, nuclear b-catenin accumulation at the tumor invasive front (TBS) failed to relate significantly with the degree of budding (p = 0.649), a finding that was reported and explained by Shinto et al. [18] stating that forms of budding that result from loss of cell cohesion, without additional activation of invasiveness, may be less dependent on Wnt pathway dysregulation. However, in opposition to Shinto et al. [18] , in our study, nuclear b-catenin accumulation at TBS did not significantly relate with cytoplasmic pseudofragments (p = 0.675), which may be explained by limited sample size.
Thus, TB involves two independent processes. These are loss of cellular cohesion -as reflected by the degree of TBand cellular activation leading to increased invasiveness. This latter process is associated with the finding of cytoplasmic pseudo-fragments and is more dependent on dysregulation of the Wnt signaling pathway [18] .
In summary, we document that pankeratin immunostain facilitates accurate assessment of TB compared to conventional H&E, and also highlights the phenomenon of cytoplasmic pseudo-fragmentation. Nuclear b-catenin accumulation at TBS denotes occurrence of EMT with underlying aberrations of E-cadherin mediated adhesion. This is followed by cell activation and increased invasiveness that is dependant on Wnt pathway dysregulation as reflected by cytoplasmic pseudofragmentation. Thus, the extent of budding and cytoplasmic pseudo-fragments is indicative of different mechanisms of tumor aggressiveness. Cut-offs should be uniformly defined before TB enters routine surgical pathology practice, and before establishing TB as a CRC prognosticator beyond TNM. Other studies in the field of TB are highly needed to uncover its underlying cellular biologic basis.
